{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:22:25Z","timestamp":1790803345715,"version":"4.1.0"},"reference-count":167,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1517\/13543784.15.6.603","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T16:49:32Z","timestamp":1149007772000},"page":"603-623","source":"Crossref","is-referenced-by-count":34,"title":["Development potential of rifalazil and other benzoxazinorifamycins"],"prefix":"10.1517","volume":"15","author":[{"given":"David M","family":"Rothstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Shalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sternlicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Ann","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,5,30]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18450"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"BROGDEN RN, FITTON A: Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.Drugs(1994) 47(6):983-1009.","DOI":"10.2165\/00003495-199447060-00008"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.2.255"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E407"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.1972-1976.2001"},{"key":"CIT0006","unstructured":"BATTEIGER B, McCORMACK W, STAMM W: A double-blind, randomized trial of rifalazil (rfz) for the treatment of nongonococcal urethritis (ngu) and Chlamydial infection.44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (October 30 \u2013 November 2 2004) (Abstract l-992b)."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2174\/1570163043334811"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383287"},{"key":"CIT0009","author":"TOMIOKA","journal-title":"Curr. Pharm. Des"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.11.1317"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.18.2229"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.43.5.1072","volume":"43","author":"AKADA","year":"1999","journal-title":"Antimicrob. Agents Chemother"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3975-3979.2004"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.4.525"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1053\/srin.2000.18074"},{"key":"CIT0016","first-page":"222","author":"FLAMM","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421709"},{"key":"CIT0018","first-page":"439","volume":"46","author":"COOKSON","year":"1997","journal-title":"J. Med. Microbiol."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/oso\/9780195081039.003.0085","author":"ZIMMERLI","year":"1998","journal-title":"Clinical infectious diseases \u2013 a practical approach"},{"key":"CIT0020","unstructured":"MURPHY CK, VAN DUZER J:In vitroactivity of novel rifamycins against rifamycin-resistant and sensitive strains ofPropionibacterium acnes.44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (October 30 \u2013 November 2 2004):185 (Abstract e-2053)."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.12.1584"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1135-1136.2003"},{"key":"CIT0023","first-page":"146","volume":"14","author":"SENSI","year":"1959","journal-title":"Farmaco Ed. Sci"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1489"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"CAMPBELL EA, KORZHEVA N, MUSTAEV Aet al.: Structural mechanism for rifampicin inhibition of bacterial RNA polymerase.Cell(2001) 104:901-912","DOI":"10.1016\/S0092-8674(01)00286-0"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.827-834.2006"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1118"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/JB.97.2.761-768.1969","volume":"97","author":"LANCINI","year":"1969","journal-title":"J. Bacteriol"},{"key":"CIT0029","unstructured":"STAMM WE, GEISLER WM, SUCHLAND RJ: Assessment of antimicrobial resistance inChlamydia trachomatisstrains associated with treatment failure or same strain recurrence. In:Chlamydial infections: proceeding of the 105h international symposium on human Chlamydial infections, Antalya, Turkey (2002):353-360."},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.440"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1128\/AAC.40.12.2749","volume":"40","author":"HOSOE","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0032","unstructured":"CHEN Y-X1, LARSSON M, PIENIASZEK Het al.: The pharmacokinetics of ABI-0043, a novel rifamycin antibacterial, in healthy beagle dogs and male Sprague-Dawley rats following oral and intravenous administration.45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (December 16 \u2013 19 2005):223 (Abstract f-2047)."},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"MAE T, KONISHI E, HOSOE K, HIDAKA T: Isolation and identification of major metabolites of rifalazil in mouse and human.Xenobiotica(1999) 29:1073-1087.","DOI":"10.1080\/004982599237967"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9801106"},{"key":"CIT0035","first-page":"m1103","volume":"6","author":"CHEN","year":"2004","journal-title":"AAPS J."},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"MAE T, INABA T, KONISHI Eet al.: Identification of enzymes responsible for rifalazil metabolism in human liver microsomes.Xenobiotica(2000) 30(6):565-74.","DOI":"10.1080\/004982500406408"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"HOSOE K, MAE T, YAMASHITA Ket al.: Identification and antimicrobial activity of urinary metabolites of a rifamycin derivative in dog.Xenobiotica(1996) 26:321-332.","DOI":"10.3109\/00498259609046711"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.9.985"},{"key":"CIT0039","doi-asserted-by":"crossref","unstructured":"MAE T, HOSOE K, YAMAMOTO Tet al.: Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog.Xenobiotica(1998) 28:759-766.","DOI":"10.1080\/004982598239173"},{"key":"CIT0040","first-page":"w5050","volume":"7","author":"CHEN","year":"2005","journal-title":"AAPS J"},{"key":"CIT0041","first-page":"224","author":"FARQUHAR","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-49-2-415"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-51-1-249"},{"key":"CIT0044","first-page":"1","volume":"40","year":"1991","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-005-0047-x"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1136\/sti.76.3.156"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.6.717"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0324-4"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/21.Supplement_3.S244"},{"key":"CIT0050","first-page":"1","volume":"42","year":"1993","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1363\/3601104"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2000.00059.x"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MMBR.58.4.686-699.1994","volume":"58","author":"BEATTY","year":"1994","journal-title":"Microbiol. Rev"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.12.3288-3297.2000"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01504-0"},{"key":"CIT0056","first-page":"31","volume":"7","author":"ASKIENAZY-ELBHAR","year":"1999","journal-title":"Infect. Dis. Obstet. Gynecol"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1086\/315778"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.2741\/hahn"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.2.593"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.636-642.2003"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.439-444.2006"},{"key":"CIT0062","first-page":"e-1437","author":"SUCHLAND","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0063","first-page":"e-1710","author":"RUPP","year":"2003","journal-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0064","unstructured":"RUPP J, ROTHSTEIN D, MAASS M: A single dose of rifalazil, a novel benzoxazinorifamycin, prevents systemic spread ofChlamydia pneumoniae-infection from the lung to the vasculature.44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (October 30 \u2013 November 2 2004) (Abstract b-1180)."},{"key":"CIT0065","doi-asserted-by":"crossref","unstructured":"VESELY JJ, PIEN FD, PIEN BCet al.: Rifampin, a useful drug for nonmycobacterial infections.Pharmacotherapy(1998) 18(2):345-357.","DOI":"10.1002\/j.1875-9114.1998.tb03861.x"},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","volume":"43","author":"WICHELHAUS","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.2.153"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1120-1126.2005"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3974-3976.2005"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.903-907.2005"},{"key":"CIT0071","unstructured":"KUO C-C, GRAYSTON JT, HIDAKA T, ROSE L M: A comparison of thein vitrosensitivity ofChlamydia pneumoniaeto macrolides and a new benzoxazinorifamycin, KRM-1648. In:Expanding indications for the new macrolides, azalides, and streptogramins. Infectious disease and therapy series. Zinner SH, Young LS, Acar JF, Neu HC (Eds), Marcel Dekker, New York, USA (1997) 21:317-321."},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1086\/513986"},{"key":"CIT0073","doi-asserted-by":"crossref","unstructured":"BLESSING E, CAMPBELL LA, ROSENFELD MEet al.:Chlamydia pneumoniaeinfection accelerates hyperlipidemia induced atherosclerotic lesion development in c57bl\/6j mice.Atherosclerosis(2001) 158(1):13-17.","DOI":"10.1016\/S0021-9150(00)00758-9"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.10.6458-6466.2005"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1086\/314855"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026531506202"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.07.011"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.2119\/2003-00009.Herrera"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.8.1437"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.23.2834"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki128"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/IAI.65.11.4832-4835.1997","volume":"65","author":"LAITINEN","year":"1997","journal-title":"Infect. Immun"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.7.633"},{"key":"CIT0084","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/CDLI.6.6.891-894.1999","volume":"6","author":"FONG","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1086\/315607"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1086\/315627"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro796"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.7.4315-4322.2005"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1086\/498617"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1902\/annals.2002.7.1.72"},{"key":"CIT0091","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/00015458.2005.11679782","volume":"105","author":"CORRADO","year":"2005","journal-title":"Acta Chir. Belg"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)80020-8"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199712050-00010"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1177\/153100350501700409"},{"key":"CIT0095","author":"MERU","year":"2005","journal-title":"Atherosclerosis"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000137913.26087.F0"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-8932(05)74070-7"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1080\/14017430050142341"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.3201\/eid0705.010503"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01368.x"},{"key":"CIT0101","author":"STAMATELOPOULOS","year":"2006","journal-title":"J. Hum. Hypertens"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2005.09.004"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90741-6"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1086\/428739"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2004.04.027"},{"key":"CIT0106","first-page":"158","volume":"82","author":"SHOR","year":"1992","journal-title":"S. Afr. Med. J"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.4.841"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00117-8"},{"key":"CIT0109","doi-asserted-by":"crossref","unstructured":"PRAGER M, TUREL Z, SPEIDL WSet al.:Chlamydia pneumoniaein carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.Stroke(2002) 33(12):2756-2761.","DOI":"10.1161\/01.STR.0000039322.66575.77"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00507-7"},{"key":"CIT0111","first-page":"6811","volume":"92","author":"KUO","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.2.585"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(97)70260-X"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.10.1501"},{"key":"CIT0115","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/JCM.34.11.2766-2769.1996","volume":"34","author":"BLASI","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.12.3397"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.2.102"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(97)70143-5"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00055-1"},{"key":"CIT0120","first-page":"142a","volume":"45","author":"MUHLESTEIN","year":"1997","journal-title":"J. Invest. Med"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.12.1613"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.11.1459"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12706-7"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043526"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043528"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.21.2641"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000200224.48947.a6"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.08.031"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000017862.08503.15"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh519"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2001.117891"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2001.01845.x"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000036748.26775.8D"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000117232.30832.EC"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2005.41.10.899611"},{"key":"CIT0136","author":"SCHULTHESS","year":"2005","journal-title":"Int. J. Cardiol"},{"key":"CIT0137","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05181-3"},{"key":"CIT0138","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200210000-00010"},{"key":"CIT0139","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70215-2"},{"key":"CIT0140","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(95)90104-3"},{"key":"CIT0141","unstructured":"ANTON PM, O\u2019BRIEN M, KELLY CPet al.: Novel rifamycins show efficacy in the clostridium difficile hamster infection model,44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (October 30 \u2013 November 2 2004):60 (Abstract b-1698)."},{"key":"CIT0142","doi-asserted-by":"crossref","unstructured":"O\u2019RIORDAN T, MATHAI E, TOBIN Eet al.: Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.Gut(1990) 31(9):999-1002.","DOI":"10.1136\/gut.31.9.999"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2005.00333.x"},{"key":"CIT0144","first-page":"151","author":"FUJII","year":"1997","journal-title":"37th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0145","first-page":"223","author":"ROTHSTEIN","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial agents and Chemotherapy,"},{"key":"CIT0146","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-7530"},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1086\/497594"},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200304000-00011"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1908-1909.2006"},{"key":"CIT0150","first-page":"206","author":"ROTHSTEIN","year":"2004","journal-title":"44th Interscience Conference On Antimicrobial Agents and Chemotherapy"},{"key":"CIT0151","first-page":"223","author":"ROTHSTEIN","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"CIT0152","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-37923"},{"key":"CIT0154","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2006.11"},{"key":"CIT0155","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.1.96"},{"key":"CIT0156","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040181"},{"key":"CIT0157","first-page":"lb-6","author":"TRAMPUZ1","year":"2005","journal-title":"45th Interscience Conference on Antimicrobial agents and Chemotherapy"},{"key":"CIT0158","first-page":"189","volume":"10","author":"GAGNON","year":"1994","journal-title":"Adv. Perit. Dial."},{"key":"CIT0159","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.900-903.2002"},{"key":"CIT0160","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb00235.x"},{"key":"CIT0161","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-005-0396-9"},{"key":"CIT0162","first-page":"CD003340","volume":"4","author":"LOEB","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"CIT0163","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.123483"},{"key":"CIT0164","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/IAI.63.8.3158-3165.1995","volume":"63","author":"VOWELS","year":"1995","journal-title":"Infect. Immun."},{"key":"CIT0165","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1535"},{"key":"CIT0166","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.6.726"},{"key":"CIT0167","first-page":"359","volume":"15","author":"SWANSON","year":"2003","journal-title":"Derm. Nursing"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.15.6.603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T15:52:40Z","timestamp":1707061960000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.15.6.603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,30]]},"references-count":167,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,5,30]]},"published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1517\/13543784.15.6.603"],"URL":"https:\/\/doi.org\/10.1517\/13543784.15.6.603","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,30]]}}}